Wen‐Chien Chou
Publications by Year
Research Areas
Acute Myeloid Leukemia Research, Myeloproliferative Neoplasms: Diagnosis and Treatment, Semiconductor Quantum Structures and Devices, Chronic Myeloid Leukemia Treatments, Lymphoma Diagnosis and Treatment
Most-Cited Works
- → Gilteritinib or Chemotherapy for Relapsed or Refractory FLT3 -Mutated AML(2019)1,191 cited
- → Multicenter, Randomized, Open-Label, Phase III Trial of Decitabine Versus Patient Choice, With Physician Advice, of Either Supportive Care or Low-Dose Cytarabine for the Treatment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia(2012)1,168 cited
- → AML1/RUNX1 mutations in 470 adult patients with de novo acute myeloid leukemia: prognostic implication and interaction with other gene alterations(2009)341 cited
- → TET2 mutation is an unfavorable prognostic factor in acute myeloid leukemia patients with intermediate-risk cytogenetics(2011)320 cited
- → DNMT3A mutations in acute myeloid leukemia: stability during disease evolution and clinical implications(2011)235 cited
- → Role of NADPH oxidase in arsenic-induced reactive oxygen species formation and cytotoxicity in myeloid leukemia cells(2004)230 cited
- → Distinct clinical and biological features of de novo acute myeloid leukemia with additional sex comb-like 1 (ASXL1) mutations(2010)225 cited
- → Distinct clinical and biologic characteristics in adult acute myeloid leukemia bearing the isocitrate dehydrogenase 1 mutation(2010)203 cited
- → The prognostic impact and stability of Isocitrate dehydrogenase 2 mutation in adult patients with acute myeloid leukemia(2010)179 cited
- → WT1 mutation in 470 adult patients with acute myeloid leukemia: stability during disease evolution and implication of its incorporation into a survival scoring system(2010)173 cited